Top 10 Stocks in focus on Friday, 17 February 2017
Domestic equity markets are likely to open in green on Friday following Nifty futures on the Singapore Stock Exchange (SGX Nifty) and mixed global cues.
Here is a list of 10 stocks that are likely to remain in focus on Friday in response to various news triggers:
LuxBSE -0.38 % Industries: Hosiery major Lux Group has been strongly contemplating merger of two unlisted entities with its publicly listed outfit Lux Industries Limited.
HDFC Bank: Foreign investors can now buy more shares in HDFC Bank as the Reserve Bank has removed restrictions imposed on it with immediate effect. The aggregate foreign shareholding through ADR/GDR/FIIs/FPIs/FDI/NRIs/PIOs in HDFC Bank have gone below the prescribed limit stipulated under the extant FDI Policy, RBI said in a notification.
Bhel, Idea CellularBSE -2.69 %, Indiabulls Housing Finance, IOC: State-run Bharat Heavy Electricals LtdBSE -1.17 % (Bhel) and telecom major Idea Cellular will move out of National Stock Exchange’s Nifty 50 index from March 31. Indiabulls Housing Finance and Indian Oil CorporationBSE 1.77 % will be included
in the index in their place.
Biocon: The Bengaluru-based Biocon and its partner Mylan Inc on Thursday said the US drug regulator USFDA has accepted Mylan’s biologics licence application (BLA) for a proposed biosimilar of branded trastuzumab for treatment of certain breast and gastric cancers.
Mahindra & Mahindra: Home-grown auto major Mahindra and MahindraBSE 0.09 % (M&M) has launched seven new models — four in the passenger van segment and three in the load carrier category — under its Supro brand. The Supro Minivan starts at Rs 4.71 lakh (ex-showroom Kolkata), while the Supro Minitruck starts at Rs 4.28 lakh (ex-showroom Kolkata).
Lupin: Drug firm LupinBSE 0.55 % has received approval from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution used for providing relief of cough. The company has received US Food and Drug Administration (USFDA) approval for its generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution (Syrup) 5 mg/1.5 mg per 5 ml, Lupin said in a BSE filing.
HavellsBSE -1.62 % India: Havells IndiaBSE -1.62 % is in advance negotiations with Lloyd Electric and Engineering to acquire its consumer durables business and get a toehold in the fastgrowing Indian air conditioners market that is dominated by global brands, multiple people involved in the talks said. Havells may do the deal for `1,200-1,500 crore, they added.
Oil and Natural GasBSE 0.10 % Corp (ONGC): The company aims to spend Rs 29,000 crore in FY2017-18, similar to the capex planned for the current fiscal year, to mostly develop its offshore oil and gas fields.
Sundaram Finance: Sundaram FinanceBSE 0.76 % will announce its financial results for the quarter ended December 31, 2016 on Friday.
NTPC: The state-owned power producer NTPCBSE -0.41 % has started production from Pakri Barwadih coal mine in Jharkhand and the first rake of the dry fuel was flagged off today.